As of 2015, one major diabetes research breakthrough is that scientists have narrowed down the number of genes that are related to the development of Type 1 diabetes, explains ScienceDaily. Another major finding is that the diabetes drug empagliflozin reduces hospitalizations and deaths due to heart failure, notes Yale News.
Scientists have gotten closer to close the location and number of genes that are involved in Type 1 diabetes, reports ScienceDaily. This could allow health care providers to more accurately identify individuals at risk for developing this disease and help people prevent it.
Many people with Type 2 diabetes also have heart failure, explains Yale News. In clinical trials, patients taking the drug empagliflozin, which lowers blood glucose and blood pressure, also experienced weight loss.